XML 44 R22.htm IDEA: XBRL DOCUMENT

Fair Value Measurements and Fair Value of Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2022

Fair Value Disclosures [Abstract]

Schedule of Cash Equivalents and Short-term Investments

The following is a summary of the Company’s cash equivalents and short-term investments (in thousands):


			December 31, 2022
			Amortized Cost Basis						Unrealized Gains						Unrealized Losses						Estimated Fair Value
Level 1
Money market funds			$	10,235					$	—					$	—					$	10,235
Level 2
U.S. government and agency securities			59,487						—						(824)						58,663
Commercial paper			102,722						—						(246)						102,476
Corporate bonds			2,059						—						(35)						2,024
Total cash equivalents and short-term investments			174,503						—						(1,105)						173,398
Less: Cash equivalents			(56,256)						—						16						(56,240)
Total short-term investments			$	118,247					$	—					$	(1,089)					$	117,158


			December 31, 2021
			Amortized Cost Basis						Unrealized Gains						Unrealized Losses						Estimated Fair Value
Level 1
Money market funds			$	10,311					$	—					$	—					$	10,311
Level 2
U.S. government and agency securities			62,268						—						(218)						62,050
Commercial paper			177,215						1						(61)						177,155
Corporate bonds			47,323						—						(39)						47,284
Total cash equivalents and short-term investments			297,117						1						(318)						296,800
Less: Cash equivalents			(25,808)						—						1						(25,807)
Total short-term investments			$	271,309					$	1					$	(317)					$	270,993